The SLC51B gene is located on chromosome 15 in humans and encodes the beta subunit of the organic solute transporter (OST) complex. The OST complex is a heterodimer composed of two subunits: OST-alpha (SLC51A) and OST-beta (SLC51B). The beta subunit is essential for the proper functioning of the OST complex, as it modulates the glycosylation, membrane trafficking, and stability of the alpha subunit .
The primary function of the OST complex is to facilitate the export of bile acids from enterocytes (intestinal cells) into the portal blood, which is a critical step in the enterohepatic circulation of bile acids. The OST complex efficiently transports major bile acid species, such as taurocholate, and can also transport steroids like estrone 3-sulfate and dehydroepiandrosterone 3-sulfate. Additionally, it plays a role in the transport of eicosanoids, such as prostaglandin E2 .
The proper functioning of the SLC51B gene is vital for maintaining bile acid homeostasis and overall metabolic health. Mutations or dysregulation of this gene can lead to various disorders, including bile acid malabsorption and visceral myopathy. The OST complex’s ability to transport a wide range of substrates highlights its importance in multiple physiological processes, including lipid metabolism and steroid hormone regulation .
Recombinant human SLC51B is produced using advanced biotechnological methods to study its structure, function, and potential therapeutic applications. The recombinant protein is typically expressed in suitable host cells, purified, and used in various research applications, including functional assays, structural studies, and drug development .